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Shanghai textile worker cohort (Astrakianakis et al, 2007). Although neither
the modest excess relative risks observed nor the exposure–response trend
for exposures 415 years since first exposure (Table 3) were statistically
significant, the findings are somewhat suggestive of a possible late pro-
carcinogenic effect. We do not believe that our observations on endotoxin
exposure and lung cancer risk necessarily challenge a well-established
association. Instead, we would argue that the exposure–response association
may change over time owing to complex, yet poorly understood, underlying
mechanisms. We are also not the first to report that an inverse association
between endotoxin and lung cancer risk may be time varying, diminishing
over time (Mastrangelo et al, 2005).
We have acknowledged the absence of data on risk factors other than
active smoking, such as indoor air pollution from cooking fuels and diet.
However, it is highly unlikely that either indoor air pollution or diet was
correlated with endotoxin exposure in this cohort, and thus were
probably not important confounders. Socio-economic status was
relatively homogenous in the cohort, and also was unlikely to have been
a confounder. Our exposure assessment for endotoxin (Astrakianakis
et al, 2006) did take into account temporal changes in exposure levels
during the cohort’s relevant work experience, to the extent that available
historical data permitted. Endotoxin is a highly variable exposure, and as
we noted in the paper, some exposure misclassification was inevitable.
We encourage analyses that consider temporal patterns of
association in other endotoxin-exposed study populations,
which can provide valuable insights into disease aetiology and
pathogenesis.
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Response to ‘Are the studies on cancer risk from CT scans biased by indication? Elements of
answer from a large-scale cohort study in France’
C R Muirhead*,1
1Institute of Health & Society, Newcastle University, Baddiley-Clark Building, Richardson Road, Newcastle upon Tyne, NE2 4AX, UK
Sir,
The recent paper by Journy et al (2015) addresses an important issue
regarding the interpretation of epidemiological studies of CT scans and
cancer risk. It has been suggested that raised risks reported in the studies
in Northern England (Pearce et al, 2012) and Australia (Mathews et al,
2013) might reflect the early symptoms of undetected cancer, or of factors
that predispose to cancer and which are the indications for the CT scans,
rather than an effect of the CT scans per se (Walsh et al, 2014). The study
of Journy et al–based on a cohort of children who received CT scans at
23 radiology departments in France–benefits from the availability of
information on predisposing factors for cancer. However, I have concerns
that their findings could be misinterpreted.
Table 1 here combines the results from Table 5 and Supplementary
Table 6 from the study by Journy et al. The authors have highlighted that
– for each cancer type – the estimate of the excess relative risk (ERR) per
1mGy cumulative organ dose is lower with adjustment for predisposing
factors than without such an adjustment. At face value, this might suggest
confounding by indication, reflecting higher cancer risk and potentially
higher radiation doses from CT scanning among children with
predisposing factors compared with children without such factors.
However, Table 1 here also shows that – for each cancer type – the ERR
among children without predisposing factors is at least as large as
the unadjusted value for the cohort overall, whereas the ERR among
children with predisposing factors is close to zero. This suggests that
the difference between the unadjusted and adjusted values principally
reflects modification of the ERR by predisposing factors, rather than
confounding.
It is unclear from the study by Journy et al to what population the
adjusted ERR estimates apply. Looking at Table 1, the adjusted estimates
appear to be similar to a weighted average of the ERR estimates for those
either with or without a predisposing factor, with weighting based on the
numbers of cancer cases in each group. This would suggest that the
adjusted estimates reflect the prevalence of predisposing factors among
those children who developed cancer. However, from a public health
perspective, it is more relevant to consider the prevalence of predisposing
factors in the general population, rather than in the selected population
Table 1. Number of cases and associated risks of primary tumours of the CNS, leukaemia, and lymphoma
CNS cancer Leukaemia Lymphoma
Cases IR ERR 95% CIa Cases IR ERR 95% CI Cases IR ERR 95% CI
All children 22 9.4 17 7.3 19 8.1
Unadjusted for predisposing factorsb 0.022  0.016, 0.061 0.057  0.079; 0.193 0.018  0.068; 0.104
Adjusted for predisposing factors 0.012  0.013, 0.037 0.047c  0.065; 0.159 0.008  0.057; 0.073
Children without a predisposing factor 15 6.4 0.028 n.a. 12 5.2 0.187 n.a. 12 5.2 0.025 n.a.
Children with a predisposing factor 7 565.9  0.005 n.a. 5 128.0  0.012 n.a. 7 160.3  0.005 n.a.
Abbreviations: CNS¼ central nervous system; CI¼ confidence interval; ERR¼excess relative risk; IR¼ incidence rate; n.a.¼ not available. The table provides the IR per 100 000 person-years,
ERR related to cumulative organ dose (in mGy) from CT scans, for all children (without and with adjustment for predisposing factors), and separately for children with and without predisposing
factors, with a 2-year exclusion period (based on Journy et al, 2015).
aWald-based CI for the ERR.
bFactors predisposing specifically to cancer at the site specified.
cListed as 0.045 in Supplementary Table 6 of Journy et al.
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of cancer patients. Fewer than 4% of the children in the cohort of Journy
et al had a predisposing factor and the correspondence percentage for the
general population is likely to be lower still, given that children with a
predisposing factor may be more likely to receive CT scans than other
children. On that basis, the ERR estimates specific to children without a
predisposing factor would seem to be much more relevant to the general
population than the adjusted estimates of Journy et al.
In view of the small number of cases in this study, inferences are
limited. Further follow-up of this cohort and results from other studies
that collect information on predisposing factors (e.g., Meulepas et al,
2014) would be valuable in providing further insights. Nevertheless, the
findings of Journy et al do not indicate that the association between
cancer risk and radiation exposure from CT scans has been confounded
by predisposing factors for cancer.
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Comment on ‘Are the studies on cancer risk from CT scans biased by indication? Elements
of answer from a large-scale cohort study in France’—Evidence of confounding by
predisposing factors unclear
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Sir,
The paper by Journy et al (2015) presents the first results of a very
carefully conducted cohort study of paediatric computerised tomography
(CT) patients from France, part of the European collaborative study ‘EPI-
CT’ (Bosch de Basea et al, submitted). Because of criticisms raised about
the results of previous studies of CT patients (Pearce et al, 2012; Mathews
et al, 2013; Huang et al, 2014), the authors made particular efforts to
collect information on potential factors which could invalidate estimates
of radiation risks in these studies. The current paper emphasises, in
particular, the potential impact of predisposing factors (PFs) for
leukaemia, central nervous system (CNS) tumours and lymphoma, the
outcomes under study in this paper. For this study, a list of PFs was
developed by paediatric oncologists based on the literature, and
hospitalised discharge records of cohort members were searched to
identify cohort members with PFs. These included familial adenomatous
polyposis, multiple endocrine neoplasia, retinocytoma, Fanconi anaemia,
ataxia telangiectasia, neurofibromatosis, other phacomatoses, xeroderma
pigmentosum, Down syndrome, Noonan syndrome, Klinefelter syn-
drome and Bloom syndrome as well as immune deficiencies (HIV/AIDS,
severe combined immune deficiency, Wiskott–Aldrich syndrome,
common variable immune deficiency and organ transplantation). The
frequency of PFs for CNS tumours in the cohort was 0.54%; it was 1.7%
and 1.6%, respectively, for PFs of leukaemia and lymphoma. The most
frequent PFs were organ transplantation (observed in 749 of the 67 274
members of the cohort  1.11%), HIV/AIDS (0.36%), Down syndrome
(0.3%), neurofibromatosis types 1 and 2 (0.16%) and other phacomatoses
(0.29%). These percentages, though low, are greater than in the general
population and their presence appears to be related to a slightly increased
frequency and slightly decreased age at CT examinations, thus potentially
confounding the association between radiation from CTs and risks of the
aforementioned neoplasms.
During the study period, 27 CNS tumours, 25 leukaemia and 21
lymphoma were observed in the cohort; of these 7, 5 and 7, respectively, had
a PF for CNS, leukaemia or lymphoma. In Table 5 of their paper, the
authors show that adjustment for PFs reduced the excess relative risk
estimates related to cumulative doses from CT scans (Table 1). This led
them to conclude ‘This study suggests that the indication for examinations,
whether suspected cancer or PF management, should be considered to avoid
overestimation of the cancer risks associated with CT scans’. Results shown
in their Supplementary Table 6, however, focusing on the ERR/mGy among
subjects with and without PF, challenge, in our opinion, this interpretation.
Indeed, risk estimates among subjects with no PF are similar
to—although slightly higher than—the unadjusted risk estimates for brain
tumours and lymphoma (see Table 1). This observation suggests that PFs
are not, in fact, confounders of the association between cumulative organ
radiation dose from CT and risk of these tumours, but rather possible effect
modifiers. Though the authors conducted tests of homogeneity of risks
between subjects with and without PFs, they were based on small numbers
of subjects and hence the power to formally identify effect modification was
very limited. For leukaemia, the ERR/mGy among subjects without PF are
Table 1. Number of cases (N) and ERR per mGy for tumours of the CNS, leukaemia and lymphoma, crude or adjusted for the
presence of PFs and by patient’s characteristics regarding presence of factors predisposing specifically to cancer at the site
specified (PF)
All cases (2-year exclusion period) Subgroups
Unadjusted Adjusted for PF Without PF With PF
N ERR/mGy (95% CI) ERR/mGy (95% CI) N ERR/mGya N ERR/mGya
CNS tumours 22 0.022 ( 0.016; 0.061) 0.012 ( 0.013; 0.037) 15 0.028 7 0.005
Leukaemia 17 0.057 ( 0.079; 0.193) 0.047 ( 0.065; 0.159) 12 0.187 5 0.012
Lymphoma 19 0.018 ( 0.068; 0.104) 0.008 ( 0.057; 0.073) 12 0.025 7 0.005
Abbreviations: CNS¼ central nervous system; ERR¼excess relative risks; PF¼predisposing factor.
aConfidence intervals not provided.
LETTERS TO THE EDITOR
*Correspondence: Dr CR Muirhead; E-mail: Colin.Muirhead@Newcastle.ac.uk
& 2015 Cancer Research UK. All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/3.0/
1842 www.bjcancer.com
